Hoosier drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, as well as hospitalizations and ER visits for patients with mild or moderate COVID-19.
Eli Lilly and Company announced the partial results Wednesday in a news release. Their findings have not yet been published or reviewed by independent scientists.
The drug is reportedly similar to one that President Donald Trump received late last week from a different company.
(10-23-2020) NE Indiana Unemployment Rates Down In September 2020
(10-23-2020) Ohio Man Sentenced To 70 Months In Prison
(10-22-2020) Trine Hosting Virtual College Fair on Nov. 19
(10-22-2020) Trine's Next Door Neighbors Award Benefits Area Students
(10-22-2020) Conference USA's Philippi to Speak at Trine Virtual Event
(10-22-2020) New Indiana FFA Director Announced
(10-22-2020) All Trine Education Majors Employed for 8th Straight Year
(10-22-2020) Train Vs. Semi Accident for the Second Day in a Row
(10-22-2020) Indiana Governor Announces Long-Term Care Facilities Plan
(10-21-2020) September Indiana Employment Report
(10-21-2020) Indiana Governor Takes Criticism in Last Night's Debate
(10-20-2020) Williams County Police Department Identify Offender
(10-20-2020) Indiana Governor Debate Changed to Virtual Format
(10-19-2020) Absentee Ballot Deadline
(10-19-2020) Indiana's Rental Assistance Portal